CIK 0001894525 · <br>Emerging growth company
Apimeds Pharmaceuticals US, Inc.
Sign in to watch- Ticker
- APUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851099700
- Phone
- 848-201-5010
- Business address
- 100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-14 | Kim Christopher Chairman and CMO | Purchase | +7,730 | $1.86 | $14K | 27,500 |
| 2025-05-13 | Kim Christopher Chairman and CMO | Purchase | +19,770 | $1.82 | $36K | 19,770 |
| 2025-05-12 | Koo Jakap Director | Purchase | +28,500 | $1.99 | $57K | 643,885 |
| 2025-05-12 | Inscobee Inc. 10% owner | Purchase | +500,000 | $4.00 | $2.0M | 1,984,616 |
Page 1 of 1 · 4 trades